Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
33
# OF OVERLAPPING
HOLDINGS
XBI
119
HOLDINGS
28%
ALSO IN WDNA
WDNA
85
HOLDINGS
39%
ALSO IN XBI
SECTOR DRIFT (XBI minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 2.2% | 4.0% | 2.2% |
|
NATERA INC | 2.1% | 4.4% | 2.1% |
|
IONIS PHARMACEUTICALS, INC. | 1.9% | 2.1% | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.9% | 2.2% | 1.9% |
|
GILEAD SCIENCES INC | 1.6% | 1.9% | 1.6% |
XBI Overweight Relative to WDNA
|
AVIDITY BIOSCIENCES INC | 2.4% |
|
INSMED INC | 2.1% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.0% |
|
REVOLUTION MEDICINES, INC. | 2.0% |
 |
ROIVANT SCIENCES LTD. | 2.0% |
|
EXACT SCIENCES CORP | 1.7% |
|
INCYTE CORP | 1.7% |
|
EXELIXIS INC | 1.7% |
|
NEUROCRINE BIOSCIENCES INC | 1.7% |
|
ABBVIE INC | 1.6% |
XBI Underweight Relative to WDNA
|
BLUEPRINT MEDICINES CORP. | -3.8% |
 |
NOVOZYMES A/S-B SHARES | -3.2% |
|
NATERA INC | -2.3% |
|
ELI LILLY & CO | -2.3% |
|
STOKE THERAPEUTICS, INC. | -2.1% |
 |
NOVARTIS AG | -1.9% |
|
BRIDGEBIO PHARMA, INC. | -1.8% |
|
AGIOS PHARMACEUTICALS INC | -1.8% |
|
ALNYLAM PHARMACEUTICALS INC | -1.7% |
|
LABCORP HOLDINGS | -1.7% |